methamphetamine

From Aaushi
Jump to navigation Jump to search
[1][2][3][4][5][6][7][8][9]

Pharmacokinetics

elimination via liver

Adverse effects

Drug interactions

  • any pharmaceutical agent that inhibits cyt P450 2D6 may increase methamphetamine levels

Laboratory

Mechanism of action

Notes

More general terms

Additional terms

References

  1. ↑ Clinical Guide to Laboratory Tests, 3rd ed. Teitz ed., W.B. Saunders, 1995
  2. ↑ Prescriber's Letter 13(3): 2006 Cytochrome P450 drug interactions Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=220233&pb=PRL (subscription needed) http://www.prescribersletter.com
  3. ↑ 3.0 3.1 3.2 Lineberry TW & Bostwick JM Methamphetamine abuse: a perfect storm of complications Mayo Clin Proc 2006; 81:77
  4. ↑ 4.0 4.1 Briere FN et al Prospective associations between meth/amphetamine (speed) and MDMA (ecstasy) use and depressive symptoms in secondary school students J Epidemiol Community Health doi:10.1136/jech-2011-200706 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22516739 <Internet> http://jech.bmj.com/content/early/2012/04/12/jech-2011-200706.abstract
  5. ↑ 5.0 5.1 Chang L, Oishi K, Skranes J et al. Sex-specific alterations of white matter developmental trajectories in infants with prenatal exposure to methamphetamine and tobacco. JAMA Psychiatry 2016 Nov 9; PMID: https://www.ncbi.nlm.nih.gov/pubmed/27829078
    Roos A, Donald KA. Refining the understanding of the effects of prenatal methamphetamine and tobacco exposure on the developing brain. JAMA Psychiatry 2016 Nov 9 PMID: https://www.ncbi.nlm.nih.gov/pubmed/27829080
  6. ↑ 6.0 6.1 Schurer S, Klingel K, Sandri M et al Clinical Characteristics, Histopathological Features, and Clinical Outcome of Methamphetamine-Associated Cardiomyopathy. JACC: Heart Failure. Volume 5, Issue 6, June 2017 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28571597 <Internet> http://www.heartfailure.onlinejacc.org/content/5/6/435
    Ahmad T, Schroder JN, Januzzi JL Jr. Breaking Bad. The Heartbreak of Drug Abuse. JACC: Heart Failure. Volume 5, Issue 6, June 2017 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28571598 <Internet> http://www.heartfailure.onlinejacc.org/content/5/6/446
  7. ↑ 7.0 7.1 Birath JB, Briones M, Amaya S et al. Ibudilast may improve attention during early abstinence from methamphetamine. Drug Alcohol Depend 2017 Jun 23; 178:386. PMID: https://www.ncbi.nlm.nih.gov/pubmed/2870476
  8. ↑ 8.0 8.1 Manja V, Nrusimha A, Gao Y et al Methamphetamine-associated heart failure: a systematic review of observational studies. Heart. 2022 Dec 1;heartjnl-2022-321610. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36456204 https://heart.bmj.com/content/early/2022/11/15/heartjnl-2022-321610
  9. ↑ 9.0 9.1 Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022

Database

Retrieved from "https://aaushi.info/w/index.php?title=A16775&oldid=1189539"